Navigation Links
Knome Announces KnomeDISCOVERY Research Awards Program

CAMBRIDGE, Mass., April 28 /PRNewswire/ -- Knome today announced the launch of its KnomeDISCOVERY Research Awards Program.  Given annually, the awards will fund innovative research projects that help reveal the genetic underpinnings of diseases and other important human traits. To inaugurate the program, Knome will award its exome sequencing and interpretation services to three winning research groups, each of which will study a pair of human exomes in order to answer a compelling biological question.  

Founded by Harvard geneticist George Church and led by internationally recognized scientists, clinicians, and bioinformaticians, Knome provides cutting-edge genome sequencing and interpretation services for biomedical researchers and families seeking to understand the causes of human disease.

"Genome sequence analysis is revolutionizing biomedical research.  My hope is that these awards will ignite researchers' imaginations," said George Church, Ph.D., Co-Founder & Chief Scientific Advisor of Knome. "Many experts in human disease stand to gain remarkable insights from exome sequencing, but could use guidance in interpreting the vast amount of data involved. Knome's sequence interpretation services can help such scientists play driving roles in the genomic revolution."

The company invites researchers to submit proposals before June 15, 2010; winners will be announced on July 30, 2010.  A panel of scientific advisors, led by George Church, will judge proposals on scientific merit, feasibility, and funding need.  Please see for more information.

About Knome

Human genomics for disease investigation

Based in Cambridge, Mass., Knome is a leading human genomics company focused on providing secure, state-of-the-art sequencing and analysis solutions for biomedical researchers and motivated families that seek to understand the genetic underpinnings of disease. Led by internationally recognized geneticists, clinicians, and bioinformaticians, Knome is responsible for sequencing and interpreting more genomes than any other company in the world. Knome is a privately held company. For more information, please visit

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Knome Featured in New PBS Series Faces of America with Henry Louis Gates, Jr.
2. Knome Launches First Platform-Agnostic Human Genome Sequencing and Analysis Service for Researchers
3. Scripps Announces Sale of United Medias Licensing Business for $175 Million
4. YM BioSciences announces controlled equity offering
5. MedQuist Announces Completion of Spheris Transaction
6. BIO-IT World Announces the Winners of its 2010 Best Practices Awards Program
7. Facet Solutions Announces 2 Year Data from US Pilot Study
8. Moffitt Cancer Center Announces Growing Interest in Recently Launched Prognostic Test for Non-Small Cell Lung Cancer
9. Healthcare Data Solutions Announces Latest Database, PrescriberPRO@Home.
10. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
11. Gramene Announces Scholarships for Groups Underrepresented in Science to Learn How to Use Bioinformatics and Genomics Resources
Post Your Comments:
(Date:11/25/2015)...  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced ... of Neurocrine Biosciences, will be presenting at the 27th ... York . .   ... minutes prior to the presentation to download or install ... be available on the website approximately one hour after ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary ... in their initial angel funding process. Now, they are paying it forward to ... early stage investments in the microbiome space. In this, they join other ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ("iCo" ... reported financial results for the quarter ended September ... in Canadian dollars and presented under International Financial ... States ," said Andrew Rae , ... regarding iCo-008 are not only value enriching for ...
(Date:11/24/2015)... , November 24, 2015 ... market research report "Oligonucleotide Synthesis Market by Product & ... Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & ... by MarketsandMarkets, the market is expected to reach USD ... 2015, at a CAGR of 10.1% during the forecast ...
Breaking Biology Technology:
(Date:11/11/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology company ... to announce that it will be a Sponsor of the ... be held November 17-19 in Hamburg , ... iMedNet , MedNet,s easy-to-use, proven and affordable ... been able to deliver time and cost savings of up ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... Oct. 29, 2015  Rubicon Genomics, Inc., today ... distribution of its DNA library preparation products, including ... new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been ... of NGS libraries for liquid biopsies--the analysis of ... prognostic applications in cancer and other conditions. Eurofins ...
Breaking Biology News(10 mins):